3,4-methylenedioxyamphetamine has been researched along with Failure to Thrive in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Failure to Thrive: A condition of substandard growth or diminished capacity to maintain normal function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Non-organic failure to thrive is a clinical diagnosis which should be considered in parallel with other causes of failure to thrive in infants." | 2.37 | Non-organic failure to thrive. ( Oates, RK, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oates, RK | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Failure to Thrive
| Article | Year |
|---|---|
Non-organic failure to thrive.
Topics: Affective Symptoms; Child; Child Behavior; Child Development; Child, Preschool; Energy Intake; Failu | 1984 |